Our product areas
Our portfolio is made up of specialty medicines, vaccines and general medicines. These are the three different types of products we create to prevent and treat disease.
Health impact
We prevent and treat disease with specialty medicines, vaccines and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; infectious diseases. Our strategy means intervening early to prevent and change the course of disease, helping to protect people and support healthcare systems. We’re confident in our future. With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide.
Specialty medicines
Our specialty medicines prevent and treat diseases, from asthma, cancer and HIV to autoimmune diseases like lupus.
Vaccines
Our portfolio of vaccines is one of the broadest in the industry. We deliver hundreds of millions of vaccine doses every year. Our vaccines portfolio targets infectious diseases from birth throughout adulthood.
General medicines
General medicines are usually prescribed in primary care or community settings by general healthcare practitioners. General medicines include inhalers for asthma and COPD to antibiotics. Every day, our general medicines make life better for millions of people all over the world.
Our supply chain
Our operations span the value chain from identifying, researching, developing and testing groundbreaking discoveries, to regulatory approval, manufacturing and commercialisation. Getting our medicines and vaccines to patients who need them is critical to how we improve health around the world. Our global network of 33 medicines and vaccines manufacturing sites enabled us to produce and deliver 1.64 billion packs of medicines and 389 million doses of vaccines in 2025.
We make sure that products are manufactured as efficiently as possible and meet the strictest quality standards. The highest quality standards are ensured during each step of the vaccine production process, including vaccine components, facilities and equipment, people training, qualification, certification and storage. Each of our vaccines products is produced manufactured to the same quality standard, regardless of where in the world the vaccine it will be used.
We've built an agile network, with the capacity and capability to bring the next generation of medicines to patients all over the globe.
